Industry: Service & Software
Published Date: 2026-06-16
Pages: 119 Pages
Report ld: 6769287
Request Sample
Customized Report
The global market for Pharmaceutical Analytical Testing was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Pharmaceutical Analytical Testing refers to the scientific process of evaluating pharmaceutical products and raw materials to ensure their quality, safety, and efficacy. It involves a range of tests and techniques that measure and analyze the chemical composition, physical properties, and biological activity of pharmaceutical substances. These tests are conducted in compliance with regulatory standards to verify the identity, purity, strength, and stability of drugs and ensure they meet the required specifications before being released to the market. Pharmaceutical analytical testing plays a crucial role in maintaining the integrity and effectiveness of pharmaceutical products throughout their lifecycle.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report provides a comprehensive view of the global market for Pharmaceutical Analytical Testing, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Pharmaceutical Analytical Testing market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Analytical Testing.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the Pharmaceutical Analytical Testing companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Pharmaceutical Analytical Testing revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Pharmaceutical Analytical Testing revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Pharmaceutical Analytical Testing Product Introduction
1.2 Global Pharmaceutical Analytical Testing Market Size Forecast (2021–2032)
1.3 Pharmaceutical Analytical Testing Market Trends & Drivers
1.3.1 Pharmaceutical Analytical Testing Industry Trends
1.3.2 Pharmaceutical Analytical Testing Market Drivers & Opportunities
1.3.3 Pharmaceutical Analytical Testing Market Challenges
1.3.4 Pharmaceutical Analytical Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pharmaceutical Analytical Testing Players Revenue Ranking (2025)
2.2 Global Pharmaceutical Analytical Testing Revenue by Company (2021–2026)
2.3 Key Companies’ R&D and Operations Footprint and Headquarters
2.4 Key Companies Pharmaceutical Analytical Testing Product Offerings
2.5 Key Companies General Availability (GA) Timeline for Pharmaceutical Analytical Testing
2.6 Pharmaceutical Analytical Testing Market Competitive Analysis
2.6.1 Pharmaceutical Analytical Testing Market Concentration Rate (2021–2026)
2.6.2 Top 5 and Top 10 Global Companies by Pharmaceutical Analytical Testing Revenue in 2025
2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pharmaceutical Analytical Testing revenue, 2025
2.7 Mergers & Acquisitions and Expansion
3 Segmentation Pharmaceutical Analytical Testing Market Classification
3.1 Introduction by Type
3.1.1 Bioanalytical Testing
3.1.2 Method Development & Validation
3.1.3 Stability Testing
3.1.4 Drug Substances Testing
3.1.5 Global Pharmaceutical Analytical Testing Sales Value by Type
3.1.5.1 Global Pharmaceutical Analytical Testing Sales Value by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Pharmaceutical Analytical Testing Sales Value, by Type (2021–2032)
3.1.5.3 Global Pharmaceutical Analytical Testing Sales Value, by Type (%), 2021–2032
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Laboratory and Research Institutions
4.1.2 Pharmaceutical Center
4.1.3 Other
4.2 Global Pharmaceutical Analytical Testing Sales Value by Application
4.2.1 Global Pharmaceutical Analytical Testing Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Pharmaceutical Analytical Testing Sales Value by Application (2021–2032)
4.2.3 Global Pharmaceutical Analytical Testing Sales Value by Application (%), 2021–2032
5 Segmentation by Region
5.1 Global Pharmaceutical Analytical Testing Sales Value by Region
5.1.1 Global Pharmaceutical Analytical Testing Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Pharmaceutical Analytical Testing Sales Value by Region (2021–2026)
5.1.3 Global Pharmaceutical Analytical Testing Sales Value by Region (2027–2032)
5.1.4 Global Pharmaceutical Analytical Testing Sales Value by Region (%), 2021–2032
5.2 North America
5.2.1 North America Pharmaceutical Analytical Testing Sales Value, 2021–2032
5.2.2 North America Pharmaceutical Analytical Testing Sales Value by Country (%), 2025 vs 2032
5.3 Europe
5.3.1 Europe Pharmaceutical Analytical Testing Sales Value, 2021–2032
5.3.2 Europe Pharmaceutical Analytical Testing Sales Value by Country (%), 2025 vs 2032
5.4 Asia Pacific
5.4.1 Asia Pacific Pharmaceutical Analytical Testing Sales Value, 2021–2032
5.4.2 Asia Pacific Pharmaceutical Analytical Testing Sales Value by Subregion (%), 2025 vs 2032
5.5 South America
5.5.1 South America Pharmaceutical Analytical Testing Sales Value, 2021–2032
5.5.2 South America Pharmaceutical Analytical Testing Sales Value by Country (%), 2025 vs 2032
5.6 Middle East & Africa
5.6.1 Middle East & Africa Pharmaceutical Analytical Testing Sales Value, 2021–2032
5.6.2 Middle East & Africa Pharmaceutical Analytical Testing Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pharmaceutical Analytical Testing Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Pharmaceutical Analytical Testing Sales Value, 2021–2032
6.3 United States
6.3.1 United States Pharmaceutical Analytical Testing Sales Value, 2021–2032
6.3.2 United States Pharmaceutical Analytical Testing Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Pharmaceutical Analytical Testing Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Pharmaceutical Analytical Testing Sales Value, 2021–2032
6.4.2 Europe Pharmaceutical Analytical Testing Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Pharmaceutical Analytical Testing Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Pharmaceutical Analytical Testing Sales Value, 2021–2032
6.5.2 China Pharmaceutical Analytical Testing Sales Value by Type (%), 2025 vs 2032
6.5.3 China Pharmaceutical Analytical Testing Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Pharmaceutical Analytical Testing Sales Value, 2021–2032
6.6.2 Japan Pharmaceutical Analytical Testing Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Pharmaceutical Analytical Testing Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Pharmaceutical Analytical Testing Sales Value, 2021–2032
6.7.2 South Korea Pharmaceutical Analytical Testing Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Pharmaceutical Analytical Testing Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Pharmaceutical Analytical Testing Sales Value, 2021–2032
6.8.2 Southeast Asia Pharmaceutical Analytical Testing Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Pharmaceutical Analytical Testing Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Pharmaceutical Analytical Testing Sales Value, 2021–2032
6.9.2 India Pharmaceutical Analytical Testing Sales Value by Type (%), 2025 vs 2032
6.9.3 India Pharmaceutical Analytical Testing Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Laboratory Testing
7.1.1 Laboratory Testing Profile
7.1.2 Laboratory Testing Main Business
7.1.3 Laboratory Testing Pharmaceutical Analytical Testing Products, Services, and Solutions
7.1.4 Laboratory Testing Pharmaceutical Analytical Testing Revenue (US$ Million), 2021–2026
7.1.5 Laboratory Testing Recent Developments
7.2 Eurofins Scientific
7.2.1 Eurofins Scientific Profile
7.2.2 Eurofins Scientific Main Business
7.2.3 Eurofins Scientific Pharmaceutical Analytical Testing Products, Services, and Solutions
7.2.4 Eurofins Scientific Pharmaceutical Analytical Testing Revenue (US$ Million), 2021–2026
7.2.5 Eurofins Scientific Recent Developments
7.3 SGS SA
7.3.1 SGS SA Profile
7.3.2 SGS SA Main Business
7.3.3 SGS SA Pharmaceutical Analytical Testing Products, Services, and Solutions
7.3.4 SGS SA Pharmaceutical Analytical Testing Revenue (US$ Million), 2021–2026
7.3.5 SGS SA Recent Developments
7.4 Intertek Phamaceutical Services
7.4.1 Intertek Phamaceutical Services Profile
7.4.2 Intertek Phamaceutical Services Main Business
7.4.3 Intertek Phamaceutical Services Pharmaceutical Analytical Testing Products, Services, and Solutions
7.4.4 Intertek Phamaceutical Services Pharmaceutical Analytical Testing Revenue (US$ Million), 2021–2026
7.4.5 Intertek Phamaceutical Services Recent Developments
7.5 West Pharmaceutical Services
7.5.1 West Pharmaceutical Services Profile
7.5.2 West Pharmaceutical Services Main Business
7.5.3 West Pharmaceutical Services Pharmaceutical Analytical Testing Products, Services, and Solutions
7.5.4 West Pharmaceutical Services Pharmaceutical Analytical Testing Revenue (US$ Million), 2021–2026
7.5.5 West Pharmaceutical Services Recent Developments
7.6 Toxikon
7.6.1 Toxikon Profile
7.6.2 Toxikon Main Business
7.6.3 Toxikon Pharmaceutical Analytical Testing Products, Services, and Solutions
7.6.4 Toxikon Pharmaceutical Analytical Testing Revenue (US$ Million), 2021–2026
7.6.5 Toxikon Recent Developments
7.7 Pace Analytical Services
7.7.1 Pace Analytical Services Profile
7.7.2 Pace Analytical Services Main Business
7.7.3 Pace Analytical Services Pharmaceutical Analytical Testing Products, Services, and Solutions
7.7.4 Pace Analytical Services Pharmaceutical Analytical Testing Revenue (US$ Million), 2021–2026
7.7.5 Pace Analytical Services Recent Developments
7.8 Boston Analytical
7.8.1 Boston Analytical Profile
7.8.2 Boston Analytical Main Business
7.8.3 Boston Analytical Pharmaceutical Analytical Testing Products, Services, and Solutions
7.8.4 Boston Analytical Pharmaceutical Analytical Testing Revenue (US$ Million), 2021–2026
7.8.5 Boston Analytical Recent Developments
7.9 Steris
7.9.1 Steris Profile
7.9.2 Steris Main Business
7.9.3 Steris Pharmaceutical Analytical Testing Products, Services, and Solutions
7.9.4 Steris Pharmaceutical Analytical Testing Revenue (US$ Million), 2021–2026
7.9.5 Steris Recent Developments
7.10 Catalent
7.10.1 Catalent Profile
7.10.2 Catalent Main Business
7.10.3 Catalent Pharmaceutical Analytical Testing Products, Services, and Solutions
7.10.4 Catalent Pharmaceutical Analytical Testing Revenue (US$ Million), 2021–2026
7.10.5 Catalent Recent Developments
7.11 Charles River Laboratories
7.11.1 Charles River Laboratories Profile
7.11.2 Charles River Laboratories Main Business
7.11.3 Charles River Laboratories Pharmaceutical Analytical Testing Products, Services, and Solutions
7.11.4 Charles River Laboratories Pharmaceutical Analytical Testing Revenue (US$ Million), 2021–2026
7.11.5 Charles River Laboratories Recent Developments
7.12 Merck
7.12.1 Merck Profile
7.12.2 Merck Main Business
7.12.3 Merck Pharmaceutical Analytical Testing Products, Services, and Solutions
7.12.4 Merck Pharmaceutical Analytical Testing Revenue (US$ Million), 2021–2026
7.12.5 Merck Recent Developments
7.13 Solvias
7.13.1 Solvias Profile
7.13.2 Solvias Main Business
7.13.3 Solvias Pharmaceutical Analytical Testing Products, Services, and Solutions
7.13.4 Solvias Pharmaceutical Analytical Testing Revenue (US$ Million), 2021–2026
7.13.5 Solvias Recent Developments
8 Industry Chain Analysis
8.1 Pharmaceutical Analytical Testing Value Chain
8.2 Pharmaceutical Analytical Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Cost Structure
8.3 Midstream Analysis
8.4 Downstream (Customer) Analysis
8.5 Sales Model and Sales Channelss
8.5.1 Pharmaceutical Analytical Testing Sales Model
8.5.2 Sales Channels
8.5.3 Pharmaceutical Analytical Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Pharmaceutical Analytical Testing market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-19
Pages: 119
USD 2900.00
(Single User License)
The global Pharmaceutical Analytical Testing market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-17
Pages: 98
USD 4250.00
(Single User License)
The global Pharmaceutical Analytical Testing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-11-16
Pages: 137
USD 4900.00
(Single User License)
The global market for Pharmaceutical Analytical Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-04
Pages: 85
USD 2900.00
(Single User License)
The global market for Pharmaceutical Analytical Testing was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-04
Pages: 115
USD 3950.00
(Single User License)
The global Pharmaceutical Analytical Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-21
Pages: 85
USD 2900.00
(Single User License)
The global Pharmaceutical Analytical Testing market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-19
Pages: 119
The global Pharmaceutical Analytical Testing market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-17
Pages: 98
The global Pharmaceutical Analytical Testing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-16
Pages: 137
The global market for Pharmaceutical Analytical Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-04
Pages: 85
The global market for Pharmaceutical Analytical Testing was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-04
Pages: 115
The global Pharmaceutical Analytical Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-21
Pages: 85
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now